ADAMTS9 and colorectal carcinoma: Li et al. also demonstrate that the overexpression of lncRNA ADAMTS9-AS1 inhibits cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway, suggesting that engineered exosomes encapsulated with ADAMTS9-AS1 serve as a novel therapeutic agent of CRC [114].